Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease

Antonio M. Gotto, Christopher P. Cannon, Xiujiang Susie Li, Sanskruti Vaidya, Uma Kher, Eliot A. Brinton, Michael Davidson, Jennifer E. Moon, Sukrut Shah, Hayes M. Dansky, Yale Mitchel, Philip Barter

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease'. Together they form a unique fingerprint.

Medicine & Life Sciences